We found that naringenin can inhibit the persistent inflammation caused by CSE and balance the oxidant/antioxidant system by regulating Nrf2 and its downstream genes, partially validating that the Nrf2 pathway is involved in the protection offered by naringenin against damage in the lung caused by CS. This evidence concerns the gene NFE2L2 and Cowden syndrome 1.